Found 5 matching trials
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
PHASE2The purpose of this study is to characterize the immunogenicity and safety ...
Location
GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults
PHASE2This trial will assess the immunogenicity and safety of GSK Biologicals' va...
Location
GSK Investigational Site
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
PHASE2The purpose of this observer-blind study is to determine whether GSK's avia...
Location
GSK Investigational Site
Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine
PHASE2This trial will assess the immunogenicity and safety elicited by the adjuva...
Location
GSK Investigational Site
Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
PHASE3The purpose of this study is to evaluate the safety and tolerability of GSK...
Location
GSK Investigational Site